Nivolumab Monoclonal Antibody from Japan
Nivolumab (Opdivo) human monoclonal antibody inhibits PD-1 for cancer immunotherapy applications. Bulk unmixed under HTS 3002.13.0010 as per immunological product notes for biotech proteins. Not in measured or retail forms.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Validate against WHO biological reference standards in docs
• Use refrigerated containers with continuous monitoring
• Confirm 'unmixed' status excluding solvents beyond water